Literature DB >> 3662784

Functional recovery after hip fracture.

A M Jette1, B A Harris, P D Cleary, E W Campion.   

Abstract

This investigation was designed to describe the 12-month functional recovery following hip fracture, testing the hypothesis that intensive rehabilitation would enhance the level of functional recovery. The study included 50 patients with intertrochanteric, and 25 patients with subcapital hip fractures who were admitted to the Massachusetts General Hospital teaching service (67% women, mean age = 78 yr). Twenty-nine percent of the patients died in the year after fracture. Among survivors, only 33% and 21% regained their prefracture function in five basic and six instrumental activities of daily living, respectively. Twenty-six percent regained their prefracture level of social/role functioning. There were no statistically significant differences in mortality, hospital discharge status, or pattern and level of functional recovery, between patients receiving experimental and standard approaches to hospital rehabilitation.

Entities:  

Mesh:

Year:  1987        PMID: 3662784

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  48 in total

1.  Epidemiology and socioeconomic cost of osteoporotic fractures in Greece.

Authors:  G Lyritis
Journal:  Calcif Tissue Int       Date:  1992-08       Impact factor: 4.333

2.  Predictors of functional recovery for hip fractured elders during 12 months following hospital discharge: a prospective study on a Taiwanese sample.

Authors:  Yea-Ing Lotus Shyu; Min-Chi Chen; Jersey Liang; Chi-Chuan Wu; Juin-Yih Su
Journal:  Osteoporos Int       Date:  2004-02-28       Impact factor: 4.507

3.  Exposure to medicines among patients admitted for hip fracture and the case-fatality rate at 1 year: a longitudinal study.

Authors:  A Agustí; E Pagès; A Cuxart; E Ballarín; X Vidal; J Teixidor; J Tomás; M M Villar; J-R Laporte
Journal:  Eur J Clin Pharmacol       Date:  2012-04-15       Impact factor: 2.953

4.  Age-related hip fractures in men: clinical spectrum and short-term outcomes.

Authors:  G Poór; E J Atkinson; D G Lewallen; W M O'Fallon; L J Melton
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

5.  Residual Disability, Mortality, and Nursing Home Placement After Hip Fracture Over 2 Decades.

Authors:  Danielle S Abraham; Erik Barr; Glenn V Ostir; J Richard Hebel; Justine Golden; Ann L Gruber-Baldini; Jack M Guralnik; Marc C Hochberg; Denise L Orwig; Barbara Resnick; Jay S Magaziner
Journal:  Arch Phys Med Rehabil       Date:  2018-11-02       Impact factor: 3.966

6.  A multicenter survey on profile of care for hip fracture: predictors of mortality and disability.

Authors:  S Maggi; P Siviero; T Wetle; R W Besdine; M Saugo; G Crepaldi
Journal:  Osteoporos Int       Date:  2009-05-05       Impact factor: 4.507

7.  Longitudinal construct validity of the Health Utilities Indices Mark 2 and Mark 3 in hip fracture.

Authors:  C Allyson Jones; Sheri L Pohar; David H Feeny; Ken Eng
Journal:  Qual Life Res       Date:  2013-10-01       Impact factor: 4.147

8.  Using patient reports to assess health-related quality of life after total hip replacement.

Authors:  P D Cleary; D T Reilly; S Greenfield; A G Mulley; L Wexler; F Frankel; B J McNeil
Journal:  Qual Life Res       Date:  1993-02       Impact factor: 4.147

9.  Application of SDOC Cut Points for Low Muscle Strength for Recovery of Walking Speed After Hip Fracture.

Authors:  Denise L Orwig; Jay Magaziner; Roger A Fielding; Hao Zhu; Ellen F Binder; Peggy M Cawthon; Shalender Bhasin; Rosaly Correa-de-Araujo; Todd Manini; Sheena Patel; Michelle Shardell; Thomas G Travison
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

10.  Functional outcomes and mortality vary among different types of hip fractures: a function of patient characteristics.

Authors:  Roger Cornwall; Marvin S Gilbert; Kenneth J Koval; Elton Strauss; Albert L Siu
Journal:  Clin Orthop Relat Res       Date:  2004-08       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.